JP2013014622A5 - - Google Patents

Download PDF

Info

Publication number
JP2013014622A5
JP2013014622A5 JP2012230565A JP2012230565A JP2013014622A5 JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5 JP 2012230565 A JP2012230565 A JP 2012230565A JP 2012230565 A JP2012230565 A JP 2012230565A JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5
Authority
JP
Japan
Prior art keywords
solvate
pharmaceutically acceptable
acceptable salt
compound
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012230565A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013014622A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013014622A publication Critical patent/JP2013014622A/ja
Publication of JP2013014622A5 publication Critical patent/JP2013014622A5/ja
Pending legal-status Critical Current

Links

JP2012230565A 2007-03-15 2012-10-18 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 Pending JP2013014622A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91817107P 2007-03-15 2007-03-15
US60/918,171 2007-03-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009553612A Division JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013259117A Division JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Publications (2)

Publication Number Publication Date
JP2013014622A JP2013014622A (ja) 2013-01-24
JP2013014622A5 true JP2013014622A5 (US20070167479A1-20070719-C00034.png) 2014-02-06

Family

ID=39525788

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009553612A Expired - Fee Related JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
JP2012230565A Pending JP2013014622A (ja) 2007-03-15 2012-10-18 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体
JP2013259117A Pending JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009553612A Expired - Fee Related JP5147866B2 (ja) 2007-03-15 2008-03-12 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013259117A Pending JP2014051529A (ja) 2007-03-15 2013-12-16 グルカン合成酵素阻害剤として有用であるピリダジノン誘導体

Country Status (18)

Country Link
US (1) US8232274B2 (US20070167479A1-20070719-C00034.png)
EP (2) EP2586778A3 (US20070167479A1-20070719-C00034.png)
JP (3) JP5147866B2 (US20070167479A1-20070719-C00034.png)
KR (1) KR20100049500A (US20070167479A1-20070719-C00034.png)
CN (1) CN101730692A (US20070167479A1-20070719-C00034.png)
AR (1) AR065721A1 (US20070167479A1-20070719-C00034.png)
AU (1) AU2008227100B2 (US20070167479A1-20070719-C00034.png)
BR (1) BRPI0809238A2 (US20070167479A1-20070719-C00034.png)
CA (1) CA2680583A1 (US20070167479A1-20070719-C00034.png)
CL (1) CL2008000725A1 (US20070167479A1-20070719-C00034.png)
CO (1) CO6220966A2 (US20070167479A1-20070719-C00034.png)
EC (1) ECSP099634A (US20070167479A1-20070719-C00034.png)
IL (1) IL200906A0 (US20070167479A1-20070719-C00034.png)
MX (1) MX2009009948A (US20070167479A1-20070719-C00034.png)
PE (1) PE20081882A1 (US20070167479A1-20070719-C00034.png)
RU (1) RU2009137946A (US20070167479A1-20070719-C00034.png)
TW (1) TW200902516A (US20070167479A1-20070719-C00034.png)
WO (1) WO2008115381A1 (US20070167479A1-20070719-C00034.png)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA100684C2 (uk) 2007-03-15 2013-01-25 Новартіс Аг Похідні бензилу та піридинілу як модулятори сигнального шляху hedgehog
WO2008115385A2 (en) * 2007-03-15 2008-09-25 Schering Corporation Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors
CN101801954B (zh) * 2007-09-20 2013-10-09 Irm责任有限公司 作为gpr119活性调节剂的化合物和组合物
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
EP2627635A1 (en) * 2010-10-11 2013-08-21 Axikin Pharmaceuticals, Inc. Salts of arylsulfonamide ccr3 antagonists
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
AP2014007637A0 (en) 2011-11-15 2014-05-31 Takeda Pharmaceutical Dihydroxy aromatic heterocyclic compound
US20150087628A1 (en) * 2012-04-10 2015-03-26 The Regents Of The University Of California Compositions and methods for treating cancer
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
CN103664795B (zh) * 2012-09-06 2017-10-03 华东理工大学 哒嗪酮类化合物及其用途
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US11224395B2 (en) 2012-10-05 2022-01-18 Koninklijke Philips N.V. Medical imaging system and method for providing an enhanced X-ray image
GB201222711D0 (en) * 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
CN105612152A (zh) * 2013-08-26 2016-05-25 普渡制药公司 氮杂螺[4.5]癸烷衍生物及其用途
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones
TW201735792A (zh) 2016-03-07 2017-10-16 農業保鮮股份有限公司 使用苯并氧雜硼雜環戊烯化合物和防腐氣體作為作物的抗微生物劑之協同方法
CU20190096A7 (es) * 2017-03-15 2020-10-20 Lunella Biotech Inc Compuestos derivados de 3-metil-3-hidroxi-4-[(n,n-dimetil)amino]-9-[2-(benciloxi)bencil]-1-oxa-9-azaspiro[5,5]undecano substituidos como inhibidores de la función mitocondrial y composiciones farmacéuticas que los contienen
US20210101874A1 (en) 2017-04-03 2021-04-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
CN109912476A (zh) * 2019-03-27 2019-06-21 南通宝凯化工有限公司 一种异丙氨基磺酰氯的生产工艺
CN112513029B (zh) * 2019-06-21 2023-10-24 上海翰森生物医药科技有限公司 含氮芳基磷氧化物类衍生物、其制备方法和应用
WO2021113625A1 (en) * 2019-12-06 2021-06-10 Plexxikon Inc. Compounds and methods for cd73 modulation and indications therefor
MX2022013615A (es) 2020-04-30 2022-11-16 Gilead Sciences Inc Inhibidores de macrociclo de peptidilarginina deiminasas.
WO2023204124A1 (ja) * 2022-04-20 2023-10-26 日本曹達株式会社 ピリダジノン化合物並びに農園芸用殺菌剤、殺線虫剤、および医療用・動物用抗真菌剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS565734B2 (US20070167479A1-20070719-C00034.png) * 1973-02-28 1981-02-06
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
ES540813A0 (es) 1985-02-28 1985-11-16 Abello Quimicos Farma Prod Sa Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico
JPH04235975A (ja) * 1991-01-21 1992-08-25 Nissan Chem Ind Ltd ピリダジノン誘導体および害虫防除剤
GB2256587A (en) 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
RU2004126320A (ru) * 2002-01-31 2005-04-10 Дайити Фармасьютикал Ко., Лтд. (JP) Производные имидазо [1,2-а]пиридина
DE10216144A1 (de) * 2002-04-12 2003-11-06 Bayer Ag Substituierte 2-Phenyl-3(2H)-Pyridazinone
US20050209278A1 (en) * 2002-04-25 2005-09-22 Mcdonald Joseph J Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
DK1689233T3 (da) * 2003-11-19 2012-10-15 Array Biopharma Inc Bicykliske inhibitorer af MEK
EP1750727A2 (en) * 2004-04-23 2007-02-14 Exelixis, Inc. Kinase modulators and methods of use
GB0524991D0 (en) * 2005-12-08 2006-01-18 Ge Healthcare Ltd Novel imaging agents for fibrosis
WO2007130383A2 (en) * 2006-04-28 2007-11-15 Northwestern University Compositions and treatments using pyridazine compounds and secretases
WO2008115385A2 (en) * 2007-03-15 2008-09-25 Schering Corporation Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors

Similar Documents

Publication Publication Date Title
JP2013014622A5 (US20070167479A1-20070719-C00034.png)
JP2014507446A5 (US20070167479A1-20070719-C00034.png)
JP2012107057A5 (US20070167479A1-20070719-C00034.png)
JP2017509667A5 (US20070167479A1-20070719-C00034.png)
JP2012126725A5 (US20070167479A1-20070719-C00034.png)
JP2014221779A5 (US20070167479A1-20070719-C00034.png)
JP2016518337A5 (US20070167479A1-20070719-C00034.png)
JP2011105738A5 (US20070167479A1-20070719-C00034.png)
HK1208801A1 (en) Orally administered medical composition
JP2013525444A5 (US20070167479A1-20070719-C00034.png)
JP2019516735A5 (US20070167479A1-20070719-C00034.png)
JP2012143233A5 (US20070167479A1-20070719-C00034.png)
JP2012255026A5 (US20070167479A1-20070719-C00034.png)
JP2015501783A5 (US20070167479A1-20070719-C00034.png)
JP2011006431A5 (US20070167479A1-20070719-C00034.png)
JP2015525757A5 (US20070167479A1-20070719-C00034.png)
JP2014530840A5 (US20070167479A1-20070719-C00034.png)
JP2016535100A5 (US20070167479A1-20070719-C00034.png)
TWI559929B (en) Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP2011519871A5 (US20070167479A1-20070719-C00034.png)
JP2016500312A5 (US20070167479A1-20070719-C00034.png)
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
JP2013532687A5 (US20070167479A1-20070719-C00034.png)
JP2016532632A5 (US20070167479A1-20070719-C00034.png)
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo